Licensed vaccine
AREPANRIX
FDA-licensed vaccine · ID Biomedical Corporation of Quebec · STN 125419
Key facts
| Trade name | AREPANRIX |
|---|---|
| Proper name | Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted |
| Manufacturer | ID Biomedical Corporation of Quebec |
| Submission tracking number (STN) | 125419 |
| Recent FDA documents | October 18, 2024 Approval Letter - AREPANRIX, Package Insert - AREPANRIX |
| FDA page updated | Oct 21, 2024 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: